Conversion from chronic to episodic migraine in patients treated with erenumab: real-life data from an Italian region

Conversion from chronic to episodic migraine in patients treated with erenumab: real-life data from an Italian region

Abstract Background Most patients treated with erenumab in clinical practice have chronic migraine (CM). We assessed the rate and possible predictors of conversion from CM to episodic migraine (EM) in a real-life study. Main body We performed a subgroup analysis of patients treated with erenumab fro...

Full description

Bibliographic Details
Main Authors: Raffaele Ornello, Alfonsina Casalena, Ilaria Frattale, Valeria Caponnetto, Amleto Gabriele, Giannapia Affaitati, Maria Adele Giamberardino, Maurizio Assetta, Maurizio Maddestra, Fabio Marzoli, Stefano Viola, Davide Cerone, Carmine Marini, Francesca Pistoia, Simona Sacco
Format: Article
Language:English
Published: BMC 2020-08-01
Series:The Journal of Headache and Pain
Subjects:
Chronic migraine
Calcitonin gene-related peptide
Migraine prevention
Monoclonal antibodies
Erenumab
Real-life study
Online Access:http://link.springer.com/article/10.1186/s10194-020-01171-w

Internet

http://link.springer.com/article/10.1186/s10194-020-01171-w

Similar Items